Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,628.40
(
-0.39%
)
Dow Jones
46,021.43
(
0.00%
)
Brent Oil
103.97
(
-0.45%
)
Bitcoin
70,435.00
(
0.77%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: masterlongevity post# 144187

Wednesday, 06/20/2012 10:20:30 PM

Wednesday, June 20, 2012 10:20:30 PM

Post# of 257262

IF there is a sign of clinical efficacy in the mild subset of bapineuzumab or solanezumab, then prodromal may prove successful

Fair point. It will be interesting to see those results.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now